{
  "table_name": "QUANT_PHOSPHOPROTEOME_TCGA_BREAST_CANCER_PDC_V1_17",
  "table_fullname": "TCGA_MITELMAN.TCGA_VERSIONED.QUANT_PHOSPHOPROTEOME_TCGA_BREAST_CANCER_PDC_V1_17",
  "column_names": [
    "nom_d_etude",
    "rapport_log2_d_abondance_des_proteines",
    "id_d_echantillon",
    "id_de_soumission_d_aliquot",
    "id_d_aliquot",
    "id_refseq",
    "id_de_cas",
    "sites_de_phosphorylation",
    "id_de_metadonnees_d_execution_d_aliquot"
  ],
  "column_types": [
    "TEXT",
    "TEXT",
    "TEXT",
    "TEXT",
    "TEXT",
    "TEXT",
    "TEXT",
    "TEXT",
    "TEXT"
  ],
  "description": [
    "Nom de l'étude (par exemple, Étude pilote sur le cancer du cerveau pédiatrique - Phosphoprotéome)",
    "Rapport log-moyen de l'ion rapporteur d'échantillon par rapport à la référence commune des ions de peptide associés au gène dans les acquisitions d'un échantillon biologique spécifique",
    "Identifiant PDC unique pour cet échantillon (par exemple, e8d83eb9-693a-11ea-b1fd-0aad30af8a83)",
    "ID de soumission d'aliquote attribué par le programme (par exemple, T14)",
    "Identifiant PDC unique pour cette aliquote (par exemple, e8db124a-693a-11ea-b1fd-0aad30af8a83)",
    "Identifiant unique donné à une séquence dans la base de données NCBI RefSeq",
    "Identifiant unique associé à un patient spécifique (par exemple, 24cb0fcb-63d6-11e8-bcf1-0a2705229b82)",
    "Codes à lettre unique et positions de séquence de protéine des acides aminés phosphorylés (par exemple, t304s310, t59)",
    "Identifie de manière unique l'aliquote en fonction de son utilisation dans l'expérience (en fonction du réactif de marquage et/ou de la répétition biologique)"
  ],
  "sample_rows": [
    {
      "id_de_cas": "010df72d-63d9-11e8-bcf1-0a2705229b82",
      "id_d_echantillon": "9532a8b4-6420-11e8-bcf1-0a2705229b82",
      "id_d_aliquot": "410a1984-6429-11e8-bcf1-0a2705229b82",
      "id_de_soumission_d_aliquot": "TCGA-E2-A10A-01A-12-A21V-30",
      "id_de_metadonnees_d_execution_d_aliquot": "27c280fc-5730-11e8-b664-00a098d917f8",
      "nom_d_etude": "TCGA Breast Cancer Phosphoproteome",
      "rapport_log2_d_abondance_des_proteines": "-0.669",
      "id_refseq": "NP_005392.2",
      "sites_de_phosphorylation": "s809"
    },
    {
      "id_de_cas": "010df72d-63d9-11e8-bcf1-0a2705229b82",
      "id_d_echantillon": "9532a8b4-6420-11e8-bcf1-0a2705229b82",
      "id_d_aliquot": "410a1984-6429-11e8-bcf1-0a2705229b82",
      "id_de_soumission_d_aliquot": "TCGA-E2-A10A-01A-12-A21V-30",
      "id_de_metadonnees_d_execution_d_aliquot": "27c280fc-5730-11e8-b664-00a098d917f8",
      "nom_d_etude": "TCGA Breast Cancer Phosphoproteome",
      "rapport_log2_d_abondance_des_proteines": "-2.7937",
      "id_refseq": "XP_016867019.1",
      "sites_de_phosphorylation": "s319"
    },
    {
      "id_de_cas": "010df72d-63d9-11e8-bcf1-0a2705229b82",
      "id_d_echantillon": "9532a8b4-6420-11e8-bcf1-0a2705229b82",
      "id_d_aliquot": "410a1984-6429-11e8-bcf1-0a2705229b82",
      "id_de_soumission_d_aliquot": "TCGA-E2-A10A-01A-12-A21V-30",
      "id_de_metadonnees_d_execution_d_aliquot": "27c280fc-5730-11e8-b664-00a098d917f8",
      "nom_d_etude": "TCGA Breast Cancer Phosphoproteome",
      "rapport_log2_d_abondance_des_proteines": "-1.5164",
      "id_refseq": "NP_001010000.1",
      "sites_de_phosphorylation": "t26"
    },
    {
      "id_de_cas": "010df72d-63d9-11e8-bcf1-0a2705229b82",
      "id_d_echantillon": "9532a8b4-6420-11e8-bcf1-0a2705229b82",
      "id_d_aliquot": "410a1984-6429-11e8-bcf1-0a2705229b82",
      "id_de_soumission_d_aliquot": "TCGA-E2-A10A-01A-12-A21V-30",
      "id_de_metadonnees_d_execution_d_aliquot": "27c280fc-5730-11e8-b664-00a098d917f8",
      "nom_d_etude": "TCGA Breast Cancer Phosphoproteome",
      "rapport_log2_d_abondance_des_proteines": "-1.4292",
      "id_refseq": "NP_001273510.1",
      "sites_de_phosphorylation": "s1229"
    },
    {
      "id_de_cas": "010df72d-63d9-11e8-bcf1-0a2705229b82",
      "id_d_echantillon": "9532a8b4-6420-11e8-bcf1-0a2705229b82",
      "id_d_aliquot": "410a1984-6429-11e8-bcf1-0a2705229b82",
      "id_de_soumission_d_aliquot": "TCGA-E2-A10A-01A-12-A21V-30",
      "id_de_metadonnees_d_execution_d_aliquot": "27c280fc-5730-11e8-b664-00a098d917f8",
      "nom_d_etude": "TCGA Breast Cancer Phosphoproteome",
      "rapport_log2_d_abondance_des_proteines": "-0.3319",
      "id_refseq": "NP_149129.2",
      "sites_de_phosphorylation": "s677"
    }
  ]
}